Latest News:- Epigenetics Market: Oncology is expected to lead the Application segment during 2024-2028

Epigenetics Market to grow at a CAGR of 14.75% during 2024-2028

The Epigenetics Market is expected to grow at a CAGR of 14.75% during 2023 and 2028. During this period, the market is also expected to show a growth of USD 1477.78 million. In the life sciences sector, the surge in chronic diseases and the demand for personalized medicine have driven technological advancements. One such area experiencing significant growth is enzyme technology, which involves the production, isolation, purification, and utilization of enzymes for the synthesis of drugs, peptides, and proteins. Researchers are engineering enzymes to optimize their properties, such as kinetics, thermal stability, solvent compatibility, and substrate specificity, to study gene expression. This technology is also instrumental in the pharmaceutical industry, where it is employed to create drugs for treating spinal injuries, regenerating damaged nerve tissues, and addressing severe combined immunodeficiency (SCID). 

Get more information on Epigenetics Market by requesting a sample report

The Oncology subsegment is expected to dominate the Application segment during the forecast period 

Technavio analysts predict that the Oncology subsegment will lead the Application segment during 2024 and 2028 In the burgeoning field of epigenetics, oncology represents a significant market due to the rising incidence of cancer worldwide. Epigenetic modifications, such as DNA methylation and histone modifications, play a crucial role in cancer development, both through hereditary factors and environmental influences. Epigenetics solutions, including methylation-specific PCR (MSP), are instrumental in identifying abnormal epigenetic patterns indicative of cancer. These tests provide valuable insights into the complex interplay between genetics and environmental factors in cancer development, enabling early detection and effective treatment strategies.

Here are the various ways based on which the market is segmented: 

• Application
  • Oncology
  • Non-oncology
• Product
  • Reagents
  • Kits
  • Enzymes and others
• Geography
  • North America
  • Europe
  • Asia
  • Rest of World (ROW)

Reasons to Purchase the Global Epigenetics Market Market Research Report by Technavio. What is in it for you?

• Wealth of Experience: Technavio is an established name in the world of market research. It holds an expertise of more than 20 years in the field, has published 21,000+ reports thereby extensively covering the area in various industries and range of regions
• Insight into Current Market Trends: Our research reports provide our readers insights into the latest market intelligence, competitor strategies, market trends, changes taking place in the industry and customer preferences, forecasted market opportunities that influence them to make better business decisions
• High ROI with Extensive Hands-on Research: Technavio is renowned for offering personalized market research reports as per unique business needs, delving deep into specific markets, product segments and demographics. Additionally, it is also well-known for providing high return on investments through its wide collection of data at pocket-friendly rates

There are several factors that are causing the market to flourish rising epigenetic applications in non-oncology diseases

Learn which are the obstacles that the market is experiencing in the way of its growth by accessing the free PDF report

Research Analysis Overview

Epigenetics, the study of heritable changes in gene expression without alterations to the DNA sequence, has emerged as a significant area of research in understanding various health conditions. The epigenetics market is witnessing a surge in demand due to the increasing awareness of the role of environmental factors, such as pesticides and heavy metals, in epigenetic modifications. These external stimuli have been linked to reproductive problems, cognitive function impairment, and the development of chronic diseases, including cancer. Cigarette smoke, a leading causative agent of lung cancer, has been shown to alter epigenetic pathways through DNA methylation. Epigenetic testing and products are becoming increasingly popular for the early detection and diagnosis of various cancers, including breast and cervical cancer. Epigenetic assays are also being used to understand the underlying mechanisms of autoimmune diseases and other ailments. The market for epigenetic products and services is expected to grow significantly in the coming years, as research in this field continues to unravel the complexities of gene regulation and its impact on human health.

Market Research Overview

According to Technavio, the global epigenetics market is a significant segment of the expansive life sciences tools and services market. This market encompasses organizations involved in the research and development (R&D) of various product categories, such as capital equipment, instruments, accessories, and consumables. These products are utilized for R&D on pharmaceuticals and biotechnology products, as well as laboratory diagnosis of various diseases. Additionally, the market covers life sciences-related services, including contract research, contract manufacturing, and contract sales. The global healthcare market size, as calculated by Technavio, represents the consolidated revenue generated by manufacturers of equipment, supplies, pharmaceuticals, biotechnology, and life sciences tools and services.

The Epigenetics Market is experiencing significant growth, fueled by the rising epigenetic applications in non-oncology diseases. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/